Target intelligence / Profile preview

SLC25A24 pseudogene 1 (SLC25A24P1)

Target: SLC25A24P1
Molecular classification: Other (Pseudogene)

Overview

SLC25A24 pseudogene 1 (SLC25A24P1) refers to a predicted, non-protein-coding pseudogene homologous to SLC25A24, a gene that encodes a mitochondrial ATP-Mg/Pi carrier protein involved in energy metabolism. Pseudogenes like SLC25A24P1 typically do not have established protein products or biological functions, are not considered therapeutic targets, and do not have known roles in disease, drug interactions, or safety concerns. The actual therapeutic target is the functional protein-coding gene SLC25A24, not its pseudogenes[1][5].

Beyond the preview

Go deeper on SLC25A24 pseudogene 1 (SLC25A24P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC25A24 pseudogene 1 (SLC25A24P1).

Explore the full profile